Helix TCS Inc. and Rose Capital Acquire 100% of the Preferred Stock of BioTrackTHC - Rose Capital

<img data-src="https://rosecapital.com/wp-content/themes/rosecapital/images/logo--wordmark.svg" alt="" class="site-logo--mark lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://rosecapital.com/wp-content/themes/rosecapital/images/logo--wordmark.svg" alt="" class="site-logo--mark">

<img data-src="https://rosecapital.com/wp-content/themes/rosecapital/images/logo--wordmark.svg" alt="" class="site-logo--mark lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://rosecapital.com/wp-content/themes/rosecapital/images/logo--wordmark.svg" alt="" class="site-logo--mark">

Helix TCS Inc. and Rose Capital Acquire 100% of the Preferred Stock of BioTrackTHC